<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03709433</url>
  </required_header>
  <id_info>
    <org_study_id>9528</org_study_id>
    <nct_id>NCT03709433</nct_id>
  </id_info>
  <brief_title>Open Trial of an ACT Skills Group and Mobile App for Worry</brief_title>
  <official_title>An ACT Skills Group and Mobile App for Worry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Utah State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Utah State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is an open trial of acceptance and commitment therapy (ACT) groups combined with a
      mobile app for the treatment of Generalized Anxiety Disorder (GAD). The goal of this study is
      to evaluate if ACT groups and a mobile app are efficacious and acceptable in the treatment of
      GAD.

      Study hypotheses are:

        1. Group ACT will lead to improvement in worry, anxiety, comorbid depression, functioning,
           and well-being.

        2. Group ACT will also lead to improvement in theoretically relevant processes, namely
           psychological inflexibility, anxiety-related fusion, mindfulness, and progress towards
           values.

        3. Combining a mobile app with group ACT will be credible, acceptable, and satisfactory to
           participants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants and power:

      Each group will include 6-12 participants. The target sample size is 36 participants, which
      would provide good power (0.90) to detect a medium effect size in a repeated-measures ANOVA
      with three time points and requires running at least 3 groups.

      All clinics on the Utah State University campus will be asked to refer their waitlist clients
      to the group, if appropriate (e.g., client presented with significant worry). Local private
      practitioners in the Cache Valley, Utah area may also be notified about the option to refer
      their waitlist clients to the group. Fliers will be posted on the Utah State University
      campus and in the local community and distributed to providers to provide more information on
      the study. Fliers will direct interested individuals to contact the researchers. The study
      will also be listed on the Utah State University Contextual Behavioral Science Lab website
      with a link to the pre-screening.

      Procedures:

      Individuals who contact the researchers expressing interest will be sent more information on
      study procedures and asked to complete a brief online pre-screening specific to this study.

      If potential participants are likely to be eligible based on the online pre-screening, they
      will be asked to schedule an initial assessment. They will be asked to review a consent form
      and given an opportunity to ask any questions. Those who decide to participate and sign the
      consent form will be administered the MINI International Neuropsychiatric Interview to check
      eligibility (i.e., GAD diagnosis, no serious mental illness), then asked to complete a series
      of self-report measures hosted on Qualtrics on an iPad to establish a baseline.

      The group intervention will begin when the groups are filled. There will be no cost or
      compensation for participating in the groups. They will be facilitated by two doctoral
      students with training in ACT. Participants will be informed about and trained in using the
      ACT Daily mobile app at the first group and reminded about how to use it at each weekly
      group. Reminders about using the app will also be sent weekly through email or text to
      participants in the follow-up period.

      Participants will be asked to complete a credibility questionnaire on paper at the end of the
      first session. They will be asked to complete an online post-treatment survey after the group
      sessions conclude, and a final online follow-up survey one month later.

      Intervention:

      The group therapy intervention consists of six weekly sessions of acceptance and commitment
      therapy (ACT). Each session will be two hours long. The intervention was developed based on
      established ACT protocols and adapted to fit the group format and generalized anxiety. The
      intervention uses metaphors, experiential exercises, and discussion to target the core
      elements of ACT: acceptance, defusion, present moment awareness, self-as-context, values, and
      committed action. Groups will be closed (i.e. new group members will not be added as sessions
      progress). Sessions will be video recorded for the purposes of training and supervision and
      to allow for a review of treatment fidelity.

      The ACT Daily mobile app is hosted on Qualtrics and teaches a variety of ACT skills targeting
      acceptance, defusion, present moment awareness, values, and committed action. Users will
      answer some brief questions regarding their current symptoms and psychological flexibility
      and then be recommended a tailored skill relevant to the psychological flexibility process
      that they report struggling with the most in the moment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 17, 2018</start_date>
  <completion_date type="Actual">April 15, 2020</completion_date>
  <primary_completion_date type="Actual">March 21, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All participants will receive the same active treatment (acceptance and commitment therapy groups and a mobile app)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>No masking will be used.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Penn State Worry Questionnaire (PSWQ)</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>The PSWQ is a 16-item self-report measure of problematic worry. The PSWQ has validity and reliability in clinical samples.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Penn State Worry Questionnaire (PSWQ)</measure>
    <time_frame>One month after the posttreatment survey is administered (10-14 weeks after baseline)</time_frame>
    <description>The PSWQ is a 16-item self-report measure of problematic worry. The PSWQ has validity and reliability in clinical samples.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory (STAI) - Trait Subscale</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>The Trait subscale of the STAI is a 20-item self-report measure of trait anxiety. The STAI-T has demonstrated validity and reliability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory (STAI) - Trait Subscale</measure>
    <time_frame>One month after the posttreatment survey is administered (10-14 weeks after baseline)</time_frame>
    <description>The Trait subscale of the STAI is a 20-item self-report measure of trait anxiety. The STAI-T has demonstrated validity and reliability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory-II (BDI-II)</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>The BDI-II is a 21-item measure of depressive symptoms. It had good reliability and validity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Beck Depression Inventory-II (BDI-II)</measure>
    <time_frame>One month after the posttreatment survey is administered (10-14 weeks after baseline)</time_frame>
    <description>The BDI-II is a 21-item measure of depressive symptoms. It had good reliability and validity in clinical samples.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptance and Action Questionnaire (AAQ-II)</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>The AAQ-II is a 7-item measure of psychological inflexibility. It has demonstrated good reliability and validity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptance and Action Questionnaire (AAQ-II)</measure>
    <time_frame>One month after the posttreatment survey is administered (10-14 weeks after baseline)</time_frame>
    <description>The AAQ-II is a 7-item measure of psychological inflexibility. It has demonstrated good reliability and validity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Believability of Anxious Thoughts and Feelings (BAFT) Questionnaire</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>The BAFT is a 16-item measure of fusion with anxious thoughts and feelings. It has demonstrated reliability and validity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Believability of Anxious Thoughts and Feelings (BAFT) Questionnaire</measure>
    <time_frame>One month after the posttreatment survey is administered (10-14 weeks after baseline)</time_frame>
    <description>The BAFT is a 16-item measure of fusion with anxious thoughts and feelings. It has demonstrated reliability and validity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mindful Attention Awareness Scale (MAAS)</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>The MAAS is a 15-item measure of mindful awareness of one's experience. It has demonstrated reliability and validity. Each item is rated from 1 to 6, and a mean score is of all items is taken, therefore the overall score range is 1 to 6 with higher scores indicating higher mindfulness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mindful Attention Awareness Scale (MAAS)</measure>
    <time_frame>One month after the posttreatment survey is administered (10-14 weeks after baseline)</time_frame>
    <description>The MAAS is a 15-item measure of mindful awareness of one's experience. It has demonstrated reliability and validity. Each item is rated from 1 to 6, and a mean score is of all items is taken, therefore the overall score range is 1 to 6 with higher scores indicating higher mindfulness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Valuing Questionnaire (VQ) - Progress subscale</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>The Progress subscale of the VQ is a 5-item measure of progress toward one's personal values. It has good validity and internal consistency.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Valuing Questionnaire (VQ) - Progress subscale</measure>
    <time_frame>One month after the posttreatment survey is administered (10-14 weeks after baseline)</time_frame>
    <description>The Progress subscale of the VQ is a 5-item measure of progress toward one's personal values. It has good validity and internal consistency.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS 8a Satisfaction with Social Roles and Activities</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>This scale is an 8-item measure of the degree to which one feels satisfied with their ability to participate in social roles and activities. This measure was developed through item response theory and has demonstrated good reliability and validity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS 8a Satisfaction with Social Roles and Activities</measure>
    <time_frame>One month after the posttreatment survey is administered (10-14 weeks after baseline)</time_frame>
    <description>This scale is an 8-item measure of the degree to which one feels satisfied with their ability to participate in social roles and activities. This measure was developed through item response theory and has demonstrated good reliability and validity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental Health Continuum-Short Form (MHC-SF)</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>The MHC-SF is a 14-item measure of psychological and social well-being. It has shown good reliability and validity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental Health Continuum-Short Form (MHC-SF)</measure>
    <time_frame>One month after the posttreatment survey is administered (10-14 weeks after baseline)</time_frame>
    <description>The MHC-SF is a 14-item measure of psychological and social well-being. It has shown good reliability and validity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Credibility/Expectancy Questionnaire (CEQ)</measure>
    <time_frame>At the end of the first group therapy session, 0-4 weeks after baseline</time_frame>
    <description>The CEQ is a 6-item measure of the credibility of a treatment approach and expectations of treatment outcomes. This measure has good reliability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobile app question: &quot;How much are you....Feeling nervous, anxious, or on edge&quot;</measure>
    <time_frame>Each time participants use the mobile app (intervention and follow-up period). This time period will begin 0-4 weeks after baseline and end 10-14 weeks after baseline.</time_frame>
    <description>This item was taken from the GAD-7, a well-validated measure of generalized anxiety. It will be used for an initial assessment each time participants begin to use the mobile app, and again after they practice one of the mobile app skills. It will be rated from 0-100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobile app question: &quot;How much are you....Worrying too much about different things&quot;</measure>
    <time_frame>Each time participants use the mobile app (intervention and follow-up period). This time period will begin 0-4 weeks after baseline and end 10-14 weeks after baseline.</time_frame>
    <description>This item was taken from the GAD-7, a well-validated measure of generalized anxiety. It will be used for an initial assessment each time participants begin to use the mobile app, and again after they practice one of the mobile app skills. It will be rated from 0-100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobile app question: &quot;How much are you....Feeling down, depressed, or hopeless&quot;</measure>
    <time_frame>Each time participants use the mobile app (intervention and follow-up period). This time period will begin 0-4 weeks after baseline and end 10-14 weeks after baseline.</time_frame>
    <description>This item was taken from the PHQ-9, a well-validated measure of depression. It will be used for an initial assessment each time participants begin to use the mobile app, and again after they practice one of the mobile app skills. It will be rated from 0-100.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobile app question: &quot;How much are you....Fighting your feelings&quot;</measure>
    <time_frame>Each time participants use the mobile app (intervention and follow-up period). This time period will begin 0-4 weeks after baseline and end 10-14 weeks after baseline.</time_frame>
    <description>This item assesses momentary experiential avoidance. It is lacking full validation but has been used successfully in previous mobile app research.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobile app question: &quot;How much are you....Stuck in thoughts&quot;</measure>
    <time_frame>Each time participants use the mobile app (intervention and follow-up period). This time period will begin 0-4 weeks after baseline and end 10-14 weeks after baseline.</time_frame>
    <description>This item assesses momentary cognitive fusion. It is lacking full validation but has been used successfully in previous mobile app research.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobile app question: &quot;How much are you....Running on autopilot&quot;</measure>
    <time_frame>Each time participants use the mobile app (intervention and follow-up period). This time period will begin 0-4 weeks after baseline and end 10-14 weeks after baseline.</time_frame>
    <description>This item assesses momentary inattention. It is lacking full validation but has been used successfully in previous mobile app research.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobile app question: &quot;How much are you....Disconnected from values&quot;</measure>
    <time_frame>Each time participants use the mobile app (intervention and follow-up period). This time period will begin 0-4 weeks after baseline and end 10-14 weeks after baseline.</time_frame>
    <description>This item assesses momentary values obstruction. It is lacking full validation but has been used successfully in previous mobile app research.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Evaluation Inventory-Short Form (TEI-SF)</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>The TEI-SF is a 9-item measure of treatment acceptability. In this study two items were omitted and others were revised to be appropriate for the present sample. This measure has good reliability and has been demonstrated to discriminate between different treatments.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Novel satisfaction items</measure>
    <time_frame>At posttreatment (6-10 weeks after baseline)</time_frame>
    <description>13 novel items were developed assessing satisfaction with the intervention (both overall and for specific components).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Generalized Anxiety Disorder</condition>
  <arm_group>
    <arm_group_label>ACT groups and mobile app</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive six two-hour weekly sessions of acceptance and commitment therapy (ACT) in a group format. They will also access the ACT Daily mobile app, which helps participants practice ACT skills in the moment, for the duration of the study (10-14 weeks depending on when the participant completes the baseline assessment.) Sessions use metaphors, experiential exercises, and discussion to target core ACT skills: acceptance, defusion, present-moment awareness, self-as-context, values, and committed action. The mobile app includes metaphors and experiential exercises to aid with all of these skills except self-as-context. Participants will be asked to use the app to practice these skills and to complete behavioral commitments linked to their values between sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ACT groups and mobile app</intervention_name>
    <description>See arm description.</description>
    <arm_group_label>ACT groups and mobile app</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Seeking treatment for worry

          2. Fluent in English

          3. At least 18 years old

          4. Have no serious mental illness

          5. Not currently receiving other treatment

          6. Meeting diagnostic criteria for generalized anxiety disorder

        Exclusion criteria mirror inclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Twohig, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Utah State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Utah State University</name>
      <address>
        <city>Logan</city>
        <state>Utah</state>
        <zip>84322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Fleming, J. E., &amp; Kocovski, N. L. (2014). MINDFULNESS AND ACCEPTANCE-BASED GROUP THERAPY FOR SOCIAL ANXIETY DISORDER: A Treatment Manual (2nd ed.). Retrieved from https://contextualscience.org/mindfulness_and_acceptancebased_group_therapy_for_1</citation>
  </reference>
  <reference>
    <citation>Boone, M. S., &amp; Cannici, J. (2013). Acceptance and commitment therapy (ACT) in groups. In Pistorello, J., (Ed.). Acceptance and mindfulness for counseling college students: Theory and practical applications for intervention, prevention, and outreach. Oakland, CA: New Harbinger.</citation>
  </reference>
  <reference>
    <citation>Twohig, M. (2004). ACT for OCD: Abbreviated Treatment Manual. (Unpublished treatment protocol). University of Nevada, Reno.</citation>
  </reference>
  <reference>
    <citation>Hayes, S. C., Strosahl, K., &amp; Wilson, K. G. (2012). Acceptance and Commitment Therapy, Second Edition: The Process and Practice of Mindful Change. New York: Guilford Press.</citation>
  </reference>
  <reference>
    <citation>Levin, M.E., Haeger, J. &amp; Cruz, R.A. (In Press). Tailoring acceptance and commitment therapy skill coaching in-the-moment through smartphones: Results from a randomized controlled trial. Mindfulness.</citation>
  </reference>
  <reference>
    <citation>Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28(6):487-95.</citation>
    <PMID>2076086</PMID>
  </reference>
  <reference>
    <citation>Molina, S., &amp; Borkovec, T. D. (1994). The Penn State Worry Questionnaire: Psychometric properties and associated characteristics. In G. C. L. Davey &amp; F. Tallis (Eds.), Wiley series in clinical psychology. Worrying: Perspectives on theory, assessment and treatment (pp. 265-283). Oxford, England: John Wiley &amp; Sons.</citation>
  </reference>
  <reference>
    <citation>Spielberger, C. D. (1983). State-Trait Anxiety Inventory (Form Y). Redwood City, CA: Mind Garden.</citation>
  </reference>
  <reference>
    <citation>Segal DL, Coolidge FL, Cahill BS, O'Riley AA. Psychometric properties of the Beck Depression Inventory II (BDI-II) among community-dwelling older adults. Behav Modif. 2008 Jan;32(1):3-20.</citation>
    <PMID>18096969</PMID>
  </reference>
  <reference>
    <citation>Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, Waltz T, Zettle RD. Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 2011 Dec;42(4):676-88. doi: 10.1016/j.beth.2011.03.007. Epub 2011 May 25.</citation>
    <PMID>22035996</PMID>
  </reference>
  <reference>
    <citation>Herzberg KN, Sheppard SC, Forsyth JP, Cred√© M, Earleywine M, Eifert GH. The Believability of Anxious Feelings and Thoughts Questionnaire (BAFT): a psychometric evaluation of cognitive fusion in a nonclinical and highly anxious community sample. Psychol Assess. 2012 Dec;24(4):877-91. doi: 10.1037/a0027782. Epub 2012 Apr 9.</citation>
    <PMID>22486595</PMID>
  </reference>
  <reference>
    <citation>Brown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003 Apr;84(4):822-48.</citation>
    <PMID>12703651</PMID>
  </reference>
  <reference>
    <citation>Smout, M., Davies, M., Burns, N., &amp; Christie, A. (2014). Development of the valuing questionnaire (VQ). Journal of Contextual Behavioral Science, 3, 164-172.</citation>
  </reference>
  <reference>
    <citation>Hahn EA, DeWalt DA, Bode RK, Garcia SF, DeVellis RF, Correia H, Cella D; PROMIS Cooperative Group. New English and Spanish social health measures will facilitate evaluating health determinants. Health Psychol. 2014 May;33(5):490-9. doi: 10.1037/hea0000055. Epub 2014 Jan 20.</citation>
    <PMID>24447188</PMID>
  </reference>
  <reference>
    <citation>Lamers SM, Westerhof GJ, Bohlmeijer ET, ten Klooster PM, Keyes CL. Evaluating the psychometric properties of the Mental Health Continuum-Short Form (MHC-SF). J Clin Psychol. 2011 Jan;67(1):99-110. doi: 10.1002/jclp.20741.</citation>
    <PMID>20973032</PMID>
  </reference>
  <reference>
    <citation>Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86.</citation>
    <PMID>11132119</PMID>
  </reference>
  <reference>
    <citation>Kelley, M. L., Heffer, R. W., Gresham, F. M., &amp; Elliot, S. N. (1989). Development of a modified Treatment Evaluation Inventory. Journal of Psychopathology and Behavioral Assessment, 11, 235-247. doi:10.1007/BF00960495</citation>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 9, 2018</study_first_submitted>
  <study_first_submitted_qc>October 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2018</study_first_posted>
  <last_update_submitted>June 5, 2020</last_update_submitted>
  <last_update_submitted_qc>June 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Utah State University</investigator_affiliation>
    <investigator_full_name>Michael Twohig, Ph.D.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

